APA (7th ed.) Citation

Liang, C., Lin, H., & Chu, P. (2026). <italic>UBE2C</italic> as a prognostic biomarker and immune modulator in breast cancer: Mechanistic insights and therapeutic potential. Oncologie (De Gruyter), 1. https://doi.org/10.1515/oncologie-2026-0003

Chicago Style (17th ed.) Citation

Liang, Chiao-Wei, Hung-Yu Lin, and Pei-Yi Chu. "UBE2C as a Prognostic Biomarker and Immune Modulator in Breast Cancer: Mechanistic Insights and Therapeutic Potential." Oncologie (De Gruyter) 2026: 1. https://doi.org/10.1515/oncologie-2026-0003.

MLA (9th ed.) Citation

Liang, Chiao-Wei, et al. "UBE2C as a Prognostic Biomarker and Immune Modulator in Breast Cancer: Mechanistic Insights and Therapeutic Potential." Oncologie (De Gruyter), 2026, p. 1, https://doi.org/10.1515/oncologie-2026-0003.